Form 4: STAAR Surgical CEO Exercises Stock Options
SEC Form 4 Filing
Stephen C. Farrell, President and CEO of STAAR Surgical, exercised stock options on March 5, 2025, acquiring 20,000 shares of common stock.
Summary
- Stephen C. Farrell, the President and CEO of STAAR Surgical Co., exercised stock options on March 5, 2025.
- He acquired 10,000 shares of common stock at a price of $5.54 per share and another 10,000 shares at $8.35 per share.
- Following these transactions, Farrell directly owns 35,156 shares of STAAR Surgical common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It reflects the CEO exercising previously granted stock options, which is a standard part of executive compensation.
Industry Context
This filing is a routine disclosure related to executive compensation and stock option exercises, common in publicly traded companies.
Stakeholder Impact
- The exercise of stock options by the CEO could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/24/2017 | Original date of options exercisable |
| 03/05/2025 | Date of transaction (exercise of stock options) |
| 03/06/2025 | Date of Form 4 filing |
| 06/23/2026 | Expiration date of options exercised at $5.54 |
| 08/07/2026 | Expiration date of options exercised at $8.35 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.